Cartesian Share Price
NASDAQ: RNAC | Micro Cap | HealthcareCartesian Stock Performance
Cartesian Share Price Today
As of 20 November 2026, Cartesian Therapeutics, Inc.'s share price is $5.89. The stock opened at $6.27, compared to its previous close of $6.33. During today's trading session, Cartesian Therapeutics, Inc.'s share price traded between $5.84 and $6.27, with an average price of $6.06. Over the past 52 weeks, the stock has recorded a high of $10.88 and a low of $5.66. In terms of performance, Cartesian Therapeutics, Inc.'s share price has declined by 21.68% over the last six months and is down 21.68% on a year-on-year basis.
Cartesian Share Price Chart
Cartesian Quarterly Profit & Loss
All figures in USD
Cartesian Annual Profit & Loss
All figures in USD
Cartesian Balance Sheet
All figures in USD Million
Cartesian Cash Flow
All figures in USD Million
Corporate Actions
About Cartesian
Cartesian Therapeutics Inc is a clinical-stage biopharmaceutical company pioneering cell therapy for the treatment of autoimmune diseases. The company uses technology and a manufacturing platform to introduce mRNA into cells to provide a therapeutic effect to patients suffering from a variety of autoimmune conditions. Unlike DNA, mRNA degrades naturally over time without integrating into the cell's genetic material.
Cartesian Historical Returns
| Month | Open | Close | Change % |
|---|---|---|---|
Nov 2026 | $6.30 | $5.88 | -10.23% |
Oct 2026 | $7.20 | $6.55 | -9.66% |
Sep 2026 | $9.02 | $7.25 | -27.43% |
Aug 2026 | $7.86 | $9.99 | +28.74% |
Jul 2026 | $10.30 | $7.76 | -25.53% |
Jun 2026 | $7.43 | $10.42 | +38.56% |
May 2026 | $6.33 | $7.52 | +20.80% |
Apr 2026 | $6.38 | $6.22 | +0.81% |
Mar 2026 | $7.36 | $6.17 | -18.64% |
Feb 2026 | $6.96 | $7.59 | +10.16% |
Jan 2026 | $7.23 | $6.89 | -4.31% |
Dec 2025 | $7.30 | $7.20 | -4.26% |